Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03481816
Title Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

prostate cancer


ETBX-051 + ETBX-061 + ETBX-071

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.